Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
158.14
-0.99 (-0.62%)
At close: Apr 23, 2025, 4:00 PM
158.00
-0.14 (-0.09%)
Pre-market: Apr 24, 2025, 7:32 AM EDT

Ascendis Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 2015 - 2019
Market Capitalization
9,5088,2347,1256,8247,6359,007
Upgrade
Market Cap Growth
15.57%15.57%4.41%-10.63%-15.23%35.62%
Upgrade
Enterprise Value
9,8168,4167,3476,4496,6767,922
Upgrade
Last Close Price
158.14137.67125.95122.13134.53166.78
Upgrade
PS Ratio
24.3221.8724.17124.77863.171059.02
Upgrade
PB Ratio
-86.88-75.24-44.2424.257.608.78
Upgrade
P/TBV Ratio
---24.707.648.84
Upgrade
EV/Sales Ratio
26.0722.3524.92117.92754.73931.41
Upgrade
Debt / Equity Ratio
-8.10-8.10-4.421.930.120.11
Upgrade
Asset Turnover
0.360.360.280.050.010.01
Upgrade
Inventory Turnover
0.180.180.260.12--
Upgrade
Quick Ratio
0.810.810.621.067.0313.75
Upgrade
Current Ratio
1.171.170.951.298.0314.02
Upgrade
Return on Equity (ROE)
---818.43%-101.69%-44.54%-58.36%
Upgrade
Return on Assets (ROA)
-17.38%-17.38%-29.73%-32.29%-27.35%-24.95%
Upgrade
Return on Capital (ROIC)
-27.89%-27.89%-44.83%-39.89%-29.42%-26.42%
Upgrade
Earnings Yield
-4.12%-4.75%-7.47%-9.13%-5.71%-5.69%
Upgrade
FCF Yield
-3.68%-3.87%-7.29%-7.99%-6.57%-3.96%
Upgrade
Buyback Yield / Dilution
-2.85%-2.85%-0.38%-2.37%-8.21%-8.84%
Upgrade
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q